Multiplex PCR Assays Market Expected to Achieve 13.3% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Multiplex PCR Assays Market Size By 2025?
In the past few years, the market size for multiplex pcr assays has witnessed significant growth. It is projected to rise from $1.51 billion in 2024 to $1.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.8%. Factors contributing to the historic growth encompass an increased occurrence of infectious diseases, higher government funding and support, a rise in the use of clinical diagnostics, an upsurge in genetic testing and personalized medicine, increased application in academic and research institutions, progress in bioinformatics and data analysis tools, and escalating healthcare expenditure.

How Big Is the Multiplex PCR Assays Market Size Expected to Grow by 2029?
In the coming years, the market size for multiplex pcr assays is anticipated to experience swift growth, elevating to $2.8 billion in 2029 with a compound annual growth rate (CAGR) of 13.3%. This predicted growth throughout the forecast period can be ascribed to the application areas' broadening, amplified demand for point-of-care diagnostics, the surge in personalized medicine, augmented spending on research and development, increased consciousness about health and preventive care, a greater emphasis on precision medicine, and heightened demand for precise and quick diagnostic tests. Major trends expected in the forecast period consist of the integration of next-generation sequencing (NGS), companion diagnostics, the innovation of digital PCR technology, automation, and high-throughput systems, portable devices and point-of-care, multiplexing, and customization features, artificial intelligence and machine learning incorporation, superior data management, and cloud-based solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

Which Key Market Drivers Powering Multiplex PCR Assays Market Expansion and Growth?
Anticipated growth in the multiplex PCR assay market is being driven by the escalating need for diagnostic testing. These tests, which help to confirm or rule out the occurrence of a particular disease or condition, are increasingly necessary due to the rise of chronic illnesses like cancer and diabetes, where accurate early detection is crucial for successful management. In addition, a general emphasis on preventive healthcare has underscored the importance of regular testing to spot potential future issues. Multiplex PCR assays have proven particularly useful in this regard, with their ability to simultaneously identify and study several pathogens or genetic indicators from just one sample, thus increasing the thoroughness and effectiveness of diagnostic testing. The National Health Service (NHS), a healthcare provider and hospital operator based in the U.K., revealed a surge in diagnostic activity over pre-crisis levels noted in 2023 with their report in July 2024. There was a 21% hike in tests carried out in May 2024, compared to the equivalent month of the previous year, and more specifically, 2.4 million diagnostic tests were performed in May 2024 alone. As a consequence, the growing need for diagnostic testing is predicted to spur growth in the multiplex PCR assay market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Multiplex PCR Assays Market?
Leading businesses in the multiplex PCR assays market are turning their attention toward the incorporation of automation, specifically next-gen quantitative PCR (qPCR) systems. This is in order to offer accurate and adaptable quantification of nucleic acids for improved clinical diagnostics and public health. The next-generation qPCR systems deliver high-throughput, precise, and concurrent identification of multiple targets, enhancing diagnostic precision and productivity. For example, Roche Diagnostics Corporation, a Switzerland-based provider of diagnostic system solutions, introduced the LightCycler PRO System in November 2023. This advanced qPCR platform provides high-throughput, accuracy, and simultaneous detection of multiple targets. It has enhanced temperature uniformity, upgraded software, and is compatible with over 200 LightMix Modular and 60 CE-IVD assays, boosting diagnostic precision and efficiency. This system represents the successful implementation of automation in the Multiplex PCR Assays market, promoting progress in clinical diagnostics and public health.

What Are the Emerging Segments in the Multiplex PCR Assays Market?
The multiplex pcr assays market covered in this report is segmented -

1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users

Subsegments:
1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays
2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp

Who Are the Global Leaders in the Multiplex PCR Assays Market?
Major companies operating in the multiplex PCR assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton dic*kinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

Which are the Top Profitable Regional Markets for the Multiplex PCR Assays Industry?
North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18681

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.